These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37210410)

  • 21. Racial Disparities in Overall Survival and Surgical Treatment for Early Stage Lung Cancer by Facility Type.
    Merritt RE; Abdel-Rasoul M; D'Souza DM; Kneuertz PJ
    Clin Lung Cancer; 2021 Sep; 22(5):e691-e698. PubMed ID: 33597104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
    Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
    J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States.
    Ahn JC; Lauzon M; Luu M; Noureddin M; Ayoub W; Kuo A; Sundaram V; Kosari K; Nissen N; Gong J; Hendifar A; Roberts LR; Abou-Alfa GK; Singal AG; Yang JD
    Hepatology; 2022 Dec; 76(6):1649-1659. PubMed ID: 35429171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Race and sex differences in the receipt of timely and appropriate lung cancer treatment.
    Shugarman LR; Mack K; Sorbero ME; Tian H; Jain AK; Ashwood JS; Asch SM
    Med Care; 2009 Jul; 47(7):774-81. PubMed ID: 19536007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trends and Disparities in Robotic Surgery Utilization for Non-Small Cell Lung Cancer.
    Jindani R; Rodriguez-Quintero JH; Kamel M; Zhu R; Vimolratana M; Chudgar N; Stiles B
    J Surg Res; 2024 Oct; 302():24-32. PubMed ID: 39074425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-small cell lung cancer treatment receipt and survival among African-Americans and whites in a rural area.
    Hua X; Ward KC; Gillespie TW; Lipscomb J; Goodman M
    J Community Health; 2014 Aug; 39(4):696-705. PubMed ID: 24346819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
    Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
    Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of immunotherapy utilization for non-small cell lung cancer in Texas pre- and post-regulatory approval.
    Olateju OA; Zeng Z; Zakeri M; Sansgiry SS
    Clin Transl Oncol; 2024 Aug; 26(8):1908-1920. PubMed ID: 38554190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients.
    Palazzo LL; Sheehan DF; Tramontano AC; Kong CY
    Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):926-934. PubMed ID: 30787053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Socioeconomic disparity trends in diagnostic imaging, treatments, and survival for non-small cell lung cancer 2007-2016.
    Shah M; Parmar A; Chan KKW
    Cancer Med; 2020 May; 9(10):3407-3416. PubMed ID: 32196964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).
    Chen AY; Halpern MT; Schrag NM; Stewart A; Leitch M; Ward E
    J Natl Cancer Inst; 2008 Apr; 100(7):462-74. PubMed ID: 18364506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial and Socioeconomic Disparities After Carotid Procedures.
    Vogel TR; Kruse RL; Kim RJ; Dombrovskiy VY
    Vasc Endovascular Surg; 2018 Jul; 52(5):330-334. PubMed ID: 29554858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Racial, Ethnic, and Socioeconomic Inequities in the Prescription of Direct Oral Anticoagulants in Patients With Venous Thromboembolism in the United States.
    Nathan AS; Geng Z; Dayoub EJ; Khatana SAM; Eberly LA; Kobayashi T; Pugliese SC; Adusumalli S; Giri J; Groeneveld PW
    Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e005600. PubMed ID: 30950652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mediation analyses of socioeconomic factors determining racial differences in the treatment of diffuse large B-cell lymphoma in a cohort of older adults.
    Guadamuz JS; Ozenberger K; Qato DM; Ko NY; Saffore CD; Adimadhyam S; Cha AS; Moran KM; Sweiss K; Patel PR; Chiu BC; Calip GS
    Medicine (Baltimore); 2019 Nov; 98(46):e17960. PubMed ID: 31725657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of demographics and socioeconomic status on the receipt of immunotherapy for stage III melanoma.
    Coogan AC; Blinn PA; Ritz EM; Tan A; Lunt L; Akers R; O'Donoghue C
    Surg Oncol; 2024 Dec; 57():102156. PubMed ID: 39406048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health Care Access Measures and Palliative Care Use by Race/Ethnicity among Metastatic Gynecological Cancer Patients in the United States.
    Islam JY; Saraiya V; Previs RA; Akinyemiju T
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34199732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Racial and socioeconomic disparities in fertility treatment provision for patients with polycystic ovary syndrome.
    Applebaum J; Kim EK; Sharp M; Dokras A; Shah DK
    Fertil Steril; 2024 Nov; 122(5):928-937. PubMed ID: 38909670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US.
    Moyers JT; Patel A; Shih W; Nagaraj G
    JAMA Netw Open; 2020 Sep; 3(9):e2015656. PubMed ID: 32876684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study.
    Willén L; Berglund A; Bergström S; Bergqvist M; Öjdahl-Bodén A; Wagenius G; Lambe M
    Lung Cancer; 2019 May; 131():40-46. PubMed ID: 31027696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.